Eledon Pharmaceuticals (ELDN) Profit After Tax (2013 - 2026)
Eledon Pharmaceuticals (ELDN) posted Profit After Tax of -$39.0 million for Q1 2026, down 273.92% on a QoQ basis from -$10.4 million in Q4 2025, and down 550.0% year-over-year from $8.7 million in Q1 2025.
Eledon Pharmaceuticals (ELDN) Profit After Tax (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals' Profit After Tax history runs 14 years deep, the most recent figure standing at -$39.0 million for Q1 2026.
- Quarterly Profit After Tax fell 550.0% year-over-year to -$39.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$76.8 million (down 313.82% YoY) and the FY2025 annual result came in at -$45.6 million, down 26.02% from the prior year.
- Profit After Tax was -$39.0 million for Q1 2026 at Eledon Pharmaceuticals, down from -$10.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at $77.0 million in Q3 2024 and bottomed at -$65.8 million in Q2 2023.
- A 5-year average of -$19.0 million and a median of -$11.2 million in 2025 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2023 — Profit After Tax sank 611.15% — and 2024, when it soared 877.01%.
- Eledon Pharmaceuticals' Profit After Tax stood at -$58.4 million in 2022, then jumped by 48.45% to -$30.1 million in 2023, then plunged by 48.23% to -$44.6 million in 2024, then jumped by 76.62% to -$10.4 million in 2025, then sank by 273.92% to -$39.0 million in 2026.
- Business Quant data shows ELDN's Profit After Tax at -$39.0 million in Q1 2026, -$10.4 million in Q4 2025, and -$16.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Eledon Pharmaceuticals | 5.43 Mn | -105.66 Mn | - | -39.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.00 Mn |
| Dec 31, 2025 | -10.43 Mn |
| Sep 30, 2025 | -16.13 Mn |
| Jun 30, 2025 | -11.22 Mn |
| Mar 31, 2025 | -6.00 Mn |
| Dec 31, 2024 | -44.62 Mn |
| Sep 30, 2024 | 76.97 Mn |
| Jun 30, 2024 | -44.91 Mn |
| Mar 31, 2024 | -23.63 Mn |
| Dec 31, 2023 | -30.10 Mn |
| Sep 30, 2023 | -9.91 Mn |
| Jun 30, 2023 | -65.76 Mn |
| Mar 31, 2023 | -10.77 Mn |
| Dec 31, 2022 | -58.38 Mn |
| Sep 30, 2022 | -10.47 Mn |
| Jun 30, 2022 | -9.25 Mn |
| Mar 31, 2022 | -9.86 Mn |
| Dec 31, 2021 | -8.81 Mn |
| Sep 30, 2021 | -9.82 Mn |
| Jun 30, 2021 | -7.38 Mn |